Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

BACKGROUND: Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), an...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pantaleo, Maria Abbondanza, Mandrioli, Anna, Saponara, Maristella, Nannini, Margherita, Erente, Giovanna, Lolli, Cristian, Biasco, Guido
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2012
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407789/
https://ncbi.nlm.nih.gov/pubmed/22687270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-231
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker